UNLIMITED HEART Trademark
Trademark Overview
On Wednesday, June 28, 2023, a trademark application was filed for UNLIMITED HEART with the United States Patent and Trademark Office. The USPTO has given the UNLIMITED HEART trademark a serial number of 98062753. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Friday, June 21, 2024. This trademark is owned by Unlimited Heart, LLC. The UNLIMITED HEART trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Clinical research in the field of cardiovascular health; Cloud computing featuring software for use providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Compiling data for research purposes in the field of medical science and medical consultancy; Medical and scientific research in the field of cardiovascular disease and heart health; Medical and scientific research information in the field of cardiovascular disease and heart health; Scientific research for medical purposes in the field of cardiovascular disease and heart health; Software design and development; Software development in the field of digital therapeutics; Application service provider (ASP) featuring software for use providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Application service provider (ASP) featuring software for use providing digital therapeutics in the fi...
General Information
| Serial Number | 98062753 |
| Word Mark | UNLIMITED HEART |
| Filing Date | Wednesday, June 28, 2023 |
| Status | 645 - FINAL REFUSAL - MAILED |
| Status Date | Friday, June 21, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| NOT AVAILABLE | "HEART" |
| Goods and Services | Clinical research in the field of cardiovascular health; Cloud computing featuring software for use providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Compiling data for research purposes in the field of medical science and medical consultancy; Medical and scientific research in the field of cardiovascular disease and heart health; Medical and scientific research information in the field of cardiovascular disease and heart health; Scientific research for medical purposes in the field of cardiovascular disease and heart health; Software design and development; Software development in the field of digital therapeutics; Application service provider (ASP) featuring software for use providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Application service provider (ASP) featuring software for use providing digital therapeutics in the field of cardiovascular health and cardiac arrhythmia that utilizes digital health technologies to treat and manage medical conditions; Application service provider (ASP) featuring software using artificial intelligence for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Application service provider (ASP) featuring software using artificial intelligence for providing digital therapeutics in the field of cardiovascular health and cardiac arrhythmia that utilizes digital health technologies to treat and manage medical conditions; Creating an on-line community for heart disease patients; Platform as a service (PAAS) featuring computer software platforms for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Platform as a service (PAAS) featuring computer software platforms for providing digital therapeutics in the field of cardiovascular health and cardiac arrhythmia that utilizes digital health technologies to treat and manage medical conditions; Providing information about medical research in the field of cardiovascular disease and heart health; Providing medical and scientific research information; Providing a website featuring non-downloadable software for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Providing a website featuring non-downloadable software using artificial intelligence for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Providing a website featuring resources, namely, non-downloadable software for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Providing a website featuring resources, namely, a website featuring primarily non-downloadable software for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions and also featuring non-downloadable publications in the nature of articles in the field of cardiovascular disease and heart health; Providing an interactive website featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports; Providing information about medical and scientific research; Providing on-line non-downloadable software for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Providing on-line non-downloadable software using artificial intelligence for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Providing subscription-based temporary use of on-line non-downloadable software for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Providing temporary use of non-downloadable cloud-based software for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Providing temporary use of a non-downloadable web application for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Providing temporary use of on-line non-downloadable software and applications for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Providing temporary use of on-line non-downloadable software for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Providing temporary use of on-line non-downloadable cloud computing software for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Providing temporary use of on-line non-downloadable cloud computing software using artificial intelligence for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Smartphone software design; Software as a service (SAAS) services featuring software for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Software as a service (SAAS) services featuring software for providing digital therapeutics in the field of cardiovascular health and cardiac arrhythmia that utilizes digital health technologies to treat and manage medical conditions; Software as a service (SAAS) services featuring software using artificial intelligence for providing digital therapeutics that utilizes digital health technologies to treat and manage medical and psychological conditions; Software as a service (SAAS) services featuring software using artificial intelligence for providing digital therapeutics in the field of cardiovascular health and cardiac arrhythmia that utilizes digital health technologies to treat and manage medical conditions |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 3, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | UNLIMITED HEART HEALTH AND WELLNESS, LLC |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | AMHERST, NH 03031 |
| Party Name | Unlimited Heart, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Amherst, NH 03031 |
Trademark Events
| Event Date | Event Description |
| Saturday, July 1, 2023 | NEW APPLICATION ENTERED |
| Monday, July 3, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, March 13, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, March 13, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 13, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, March 13, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, June 13, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 13, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, June 14, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, June 21, 2024 | FINAL REFUSAL E-MAILED |
| Friday, June 21, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, June 21, 2024 | FINAL REFUSAL WRITTEN |
| Thursday, September 5, 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Monday, September 23, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, September 23, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, September 23, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
